Treatment of H-Ras-driven tumors

• 收藏
• 分享

专利权人:

Memorial Sloan-Kettering Cancer Center

发明人:

FAGIN, James A.,KNAUF, Jeffrey A.,UNTCH, Brian R.

申请号：

AU2020200794

公开号：

AU2020200794A1

申请日:

2020.02.04

申请国别(地区):

AU

年份:

2020

代理人:

摘要：

#$%^&*AU2020200794A120200220.pdf#####Abstract The present disclosure describes a compositions and methods for treatment of Hras-driven cancers. 5 Administration of a farnesyltransferase inhibitor, for example, tipifarnib, alone or in combination with a MEK inhibitor can reduce tumor size and tumor growth in cancers such as poorly differentiated thyroid cancer (PDTC) and anaplastic thyroid cancer (ATC) C: NRPortbI GHMatters MICHE LES 12016791_1.docx 9/01/2013/17 0 0) ' E 000 coo 0- 0 leA!AjunsIU03Jed

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/